<?xml version='1.0' encoding='iso-8859-1'?>
<newsitem date="1997-03-24" id="root" itemid="464329" xml:lang="en">
<title>FRANCE: RPR gets Euro marketing OK for Granocyte.</title>
<headline>RPR gets Euro marketing OK for Granocyte.</headline>
<dateline>PARIS 1997-03-24</dateline>
<text>
<p>Rhone-Poulenc Rorer said it had received European Commission marketing authorisation for Granocyte for use in peripheral blood progenitor cell (PBC) mobilisation for autologous transplantation.</p>
<p>This process is a medical procedure performed on cancer patients to avoid a bone marrow transplant and enables a physician to administer high doses of chemotherapy.</p>
<p>Rhone-Poulenc Rorer is majority-owned by Rhone-Poulenc.</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<dc element="dc.date.created" value="1997-03-24" />
<dc element="dc.publisher" value="Reuters Holdings Plc" />
<dc element="dc.date.published" value="1997-03-24" />
<dc element="dc.source" value="Reuters" />
<dc element="dc.creator.location" value="PARIS" />
<dc element="dc.creator.location.country.name" value="FRANCE" />
<dc element="dc.source" value="Reuters" />
</metadata>
</newsitem>